Duff & Phelps Managing Director and Healthcare and Life Sciences industry leader Andreas Chrysostomou discusses some of the highlights of the new AICPA Accounting and Valuation Guide on IPR&D. Discussion topics include the risks of not valuing IPR&D properly, the now permissible relief from royalty method, treatment of consideration and milestone payments, and acceptable approaches for selecting the appropriate discount rate.
Watch the video